Trademark: 88925510
Word
AIVIVA BIOPHARMA
Status
Pending
Status Code
731
Status Date
Thursday, September 28, 2023
Serial Number
88925510
Mark Type
5000
Filing Date
Wednesday, May 20, 2020
Published for Opposition
Tuesday, April 12, 2022

Trademark Owner History
AiViva Biopharma, Inc. - Owner At Publication

Classifications
5 Anti-dermoinfectives; Anti-friction skin preparations for preventing blisters; Anti-friction skin preparations for preventing chafing; Antibacterial alcohol skin sanitizer gel; Antimicrobials for dermatologic use; Bandages for skin wounds; Dermatological pharmaceutical products; Gels, creams and solutions for dermatological use; Medical cleansers for skin and wounds; Medical preparations, namely, foot, hand and skin creams for diabetics; Medicaments for treating skin disorders, cancer and prostate related disorder; Medicated balms for treatment of skin; Medicated dermatological preparations and substances; Medicated lotions for treating dermatological conditions; Medicated lotions for skin; Medicated ointments for treating dermatological conditions; Medicated skin preparation for use in treating aberrant wound healing and skin cancer; Non-medicated, therapeutic skin creams for the treatment of aberrant wound healing and skin cancer; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products for skin care for animals; Preparations for cleansing the skin for medical use; Processed human donor skin for the replacement of soft tissue; Skin grafts; Topical dermatological preparations that treat insect bites and stings
42 Conducting clinical trials for others; Conducting of feasibility studies in the field of new technologies; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Conducting scientific feasibility studies; Medical research; Pharmaceutical research and development; Pharmaceutical research services; Research and development and consultation related thereto in the field of pharmaceutical research and development; Research and development in the field of skin disorders, eye related disorder, cancer and prostate related disorder; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines; Research in the field of pharmaceuticals; Research on the subject of pharmaceuticals; Scientific study and research in the field(s) of treatment and management of illness; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff
The mark consists of the word "AIVIVA" having an extended downward line on the first letter "A" and a an extended upward line on the first "V" above the word "BioPharma".
Color is not claimed as a feature of the mark.
"BIOPHARMA"

Trademark Events
Oct 10, 2023
Itu Letter Mailed, No Response Required
Oct 10, 2023
Case Assigned To Intent To Use Paralegal
Sep 29, 2023
Sou Teas Extension Received
Sep 30, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 28, 2023
Sou Extension 2 Granted
Sep 28, 2023
Sou Extension 2 Filed
Sep 28, 2023
Sou Teas Extension Received
Jan 11, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 9, 2023
Sou Extension 1 Granted
Jan 9, 2023
Sou Extension 1 Filed
Jan 9, 2023
Sou Teas Extension Received
Jan 3, 2023
Teas Change Of Correspondence Received
Jan 3, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 3, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 13, 2022
Assigned To Examiner
Oct 4, 2022
Noa E-Mailed - Sou Required From Applicant
Aug 21, 2022
Extension Of Time To Oppose Process - Terminated
May 9, 2022
Extension Of Time To Oppose Received
Apr 12, 2022
Official Gazette Publication Confirmation E-Mailed
Apr 12, 2022
Published For Opposition
Mar 23, 2022
Notification Of Notice Of Publication E-Mailed
Mar 9, 2022
Approved For Pub - Principal Register
Mar 9, 2022
Examiner's Amendment Entered
Mar 9, 2022
Notification Of Examiners Amendment E-Mailed
Mar 9, 2022
Examiners Amendment E-Mailed
Mar 9, 2022
Examiners Amendment -Written
Jan 19, 2022
Teas/Email Correspondence Entered
Jan 18, 2022
Correspondence Received In Law Office
Jan 18, 2022
Teas Response To Office Action Received
Sep 27, 2021
Notification Of Non-Final Action E-Mailed
Sep 27, 2021
Non-Final Action E-Mailed
Sep 27, 2021
Non-Final Action Written
Aug 23, 2021
Suspension Checked ¿ To Attorney For Action
Dec 3, 2020
Notification Of Letter Of Suspension E-Mailed
Dec 3, 2020
Letter Of Suspension E-Mailed
Dec 3, 2020
Suspension Letter Written
Nov 4, 2020
Teas/Email Correspondence Entered
Nov 4, 2020
Correspondence Received In Law Office
Nov 4, 2020
Teas Response To Office Action Received
Aug 20, 2020
Notification Of Non-Final Action E-Mailed
Aug 20, 2020
Non-Final Action E-Mailed
Aug 20, 2020
Non-Final Action Written
Aug 19, 2020
Assigned To Examiner
Jun 4, 2020
New Application Office Supplied Data Entered
May 23, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24